Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001354488-11-001045
Filing Date
2011-03-31
Accepted
2011-03-31 17:23:17
Documents
14
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT asch_10k.htm 10-K 2383491
2 CERTIFICATION asch_ex311.htm EX-31.1 18451
3 CERTIFICATION asch_ex312.htm EX-31.2 18452
4 CERTIFICATION asch_ex321.htm EX-32.1 8088
5 CERTIFICATION asch_ex322.htm EX-32.2 8400
6 img001.jpg GRAPHIC 8475
7 img002.jpg GRAPHIC 22014
8 img003.jpg GRAPHIC 38138
9 img004.jpg GRAPHIC 19093
10 img005.jpg GRAPHIC 17165
11 img006.jpg GRAPHIC 23587
12 img007.jpg GRAPHIC 24629
13 img008.jpg GRAPHIC 21317
14 img009.jpg GRAPHIC 18147
  Complete submission text file 0001354488-11-001045.txt   2704341
Mailing Address 4819 EMPEROR BLVD STE 400 DURHAM NC 27703
Business Address 4819 EMPEROR BLVD STE 400 DURHAM NC 27703 919-313-4930
CURAXIS PHARMACEUTICAL Corp (Filer) CIK: 0001434893 (see all company filings)

EIN.: 261919261 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-150937 | Film No.: 11727637
SIC: 2834 Pharmaceutical Preparations